Ziflomil financials
A multi-period view of the public annual-account figures reported for Ziflomil, with comparable measures and links to available source documents.
Company overviewRegistry number
0508493301
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Ziflomil
2025 versus 2024
- Operating line
- €17,170
- EBITDA
- €16,049
- Total assets
- €9,656
- Equity
- -€8,805
+129.2%
+176.5%
-84%
+59.7%
EBITDA margin +93.5% · Equity ratio -91.2%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.